Figure 1 from Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas. | Semantic Scholar
Hedgehog signaling, vismodegib action, and acquired resistance | Download Scientific Diagram
Cells control energy metabolism via hedgehog signalling pathway | Max-Planck-Gesellschaft
Cells | Free Full-Text | Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
How Erivedge Is Designed To Work | Erivedge® (vismodegib)
View of Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma | Acta Dermato-Venereologica
Frontiers | Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
Repurposing itraconazole for the treatment of cancer (Review)
Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
Vismodegib | Nature Reviews Drug Discovery
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis | Acta Neuropathologica Communications | Full Text
Cholesterol access in cellular membranes controls Hedgehog signaling | Nature Chemical Biology
Vismodegib: A Review - ScienceDirect
The story of vismodegib and basal cell carcinoma
Vismodegib (Erivedge) - Oncology Nurse Advisor
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Frontiers | The hedgehog pathway in hematopoiesis and hematological malignancy
The hedgehog pathway in triple‐negative breast cancer - Habib - 2016 - Cancer Medicine - Wiley Online Library
Click Reaction as a Tool to Combine Pharmacophores: The Case of Vismodegib - Christodoulou - 2015 - ChemPlusChem - Wiley Online Library
Vismodegib - Wikipedia
IJMS | Free Full-Text | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Hedgehog signaling inhibitors in solid and hematological cancers
